ENTA

Enanta Pharmaceuticals Inc

Jun 12 • 01:50PM ET

11.84

+0.33 2.90 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NKTR KROS INCY VKTX BMRN KRYS RYTM AXSM MDGL NBIX

| Held by: VTI IWM VXF IWN IBB VTWO SCHA DWAS VFMO IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.59	Insider Own	5.09%	Shs Outstand	29.06M	Perf Week	5.00%
Market Cap	344.41M	Forward P/E	-	EPS next Y	-1.75	Insider Trans	0.00%	Shs Float	27.60M	Perf Month	-15.58%
Enterprise Value	367.26M	PEG	-	EPS next Q	-0.45	Inst Own	92.29%	Short Float	8.24%	Perf Quarter	-6.74%
Income	-61.98M	P/S	4.98	EPS this Y	40.73%	Inst Trans	0.15%	Short Ratio	13.16	Perf Half Y	-17.58%
Sales	69.21M	P/B	2.95	EPS next Y	22.96%	ROA	-19.44%	Short Interest	2.27M	Perf YTD	-24.89%
Book/sh	4.01	P/C	2.10	EPS next 5Y	17.16%	ROE	-59.00%	52W High	17.15 -30.94%	Perf Year	59.84%
Cash/sh	5.63	P/FCF	-	EPS past 3/5Y	13.40% -16.17%	ROIC	-23.13%	52W Low	6.43 84.06%	Perf 3Y	-53.59%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.82% -11.81%	Gross Margin	92.87%	Volatility	7.78% 5.76%	Perf 5Y	-74.87%
Dividend TTM	-	EV/Sales	5.31	EPS Y/Y TTM	42.85%	Oper. Margin	-87.24%	ATR (14)	0.79	Perf 10Y	-49.23%
Dividend Ex-Date	-	Quick Ratio	3.84	Sales Y/Y TTM	7.37%	Profit Margin	-89.56%	RSI (14)	40.55	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	3.84	EPS Q/Q	57.49%	SMA20	-5.83%	Beta	1.01	Target Price	20.62
Payout	-	Debt/Eq	1.60	Sales Q/Q	14.96%	SMA50	-12.11%	Rel Volume	0.80	Prev Close	11.51
Employees	120	LT Debt/Eq	1.30	Earnings	May 11 AMC	SMA200	-6.19%	Avg Volume	172.79K	Price	11.84
IPO	Mar 21, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.65% 0.77%	Trades		Volume	95,034	Change	2.90%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)